NCT05544526View on ClinicalTrials.gov

CAR T Cells to Target GD2 for DMG

PHASE1RecruitingINTERVENTIONAL

Enrollment

12

Participants

Timeline

Start Date

August 15, 2023

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2039

Conditions

Diffuse Midline Glioma, H3 K27M-Mutant

Interventions

BIOLOGICAL

GD2 CAR T cells

Infusion with: GD2 CAR T-cells

Trial Locations (1)

Unknown

RECRUITING

Great Ormond Street Hospital, London

All Listed Sponsors

lead

University College, London

OTHER